CDC为波多黎各的病媒控制部门归档了1400万美元

On September 17, 2026, this table returns to the official CDC Online Newsroom archive — preserved at archive.cdc.gov — regarding the December 22, 2016 announcement in which the agency awarded nearly $184 million to continue the Zika response in states, territories, local jurisdictions, and universities. Within that national package there is an unequivocal peg for Puerto Rico: $14 million awarded to the Puerto Rico Science, Technology and Research Trust (ST&R Trust) to oversee the island's first Vector Control Unit (VCU), which the CDC helped establish.

The statement quotes then-director Tom Frieden: Zika continued to be a threat to pregnant women, and states and territories needed that CDC funding to protect the next generation. There is no vaccine or specific treatment in that text; transmission is described mainly by Aedes mosquitoes (Aedes aegypti and Aedes albopictus) and also sexually. Many infected people do not show symptoms, which complicates surveillance.

The national breakdown of the announcement includes nearly $97 million to 58 state, territorial, municipal, and local health departments through the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Cooperative Agreement —including $22 million in ELC emergency funds awarded earlier that fiscal year to Florida and Texas—. It also mentions more than $8 million to 38 jurisdictions to establish or strengthen pregnancy and birth surveillance activities. These are national lines; they should not be added as if they were exclusive allotments for Puerto Rico.

The clear territorial line is the VCU: $14 million to the ST&R Trust to continue comprehensive mosquito control in Puerto Rico. That figure is awarded in the sense of the CDC press release, not a snapshot of cash disbursed to each municipality. Confusing awarded with disbursed, or adding this $14 million again on top of the September 2016 award that created the unit (already filed in another note of the institutional batch), inflates the stock. They are different tranches in time: one for establishment and another for continuation in December.

The same statement explains that, with remaining supplementary funds, the CDC would continue sending response teams to states with outbreaks, offering reference laboratory capacity and a framework to track pregnancies and birth defects associated with Zika. That federal architecture—laboratory, surveillance, and vector control—is the context in which Puerto Rico appears as a priority territory with its own VCU under the Trust.

For borinquenmade.blog, the value of the primary archive is not nostalgia: it is evidence of how the CDC labeled territorial money in the midst of the 2016 emergency and which vehicle (ST&R Trust / VCU) received the award. In 2024–2025, the Island faced high dengue transmission again; the institutional memory of vector control and ELC/VCU awards remains relevant for comparing announced capacity versus sustained capacity. This note does not invent a 2026 grant: it documents the December 2016 award with a stable archive URL.

Table language rules: $184 million is the national total of the announcement; $14 million is the award to Puerto Rico for the VCU; $97 million and $8 million are multi-jurisdiction lines. Obligated and disbursed do not appear as cash metrics in the press release. Those who need the contemporary stock of dengue 2024 can cross-check with the already archived MMWR; those who need the FY2026 lead allotment, with the EPA memorandum of the sister note. Here the peg is federal public health and money awarded to Puerto Rico's vector infrastructure.

In summary of September 17: the CDC file of December 22, 2016, holds an award of $14 million to the ST&R Trust for the Puerto Rico Vector Control Unit within a national package of nearly $184 million. Without inventing subsequent disbursements, the note leaves a clean documentary trail for the track of aid and health governance.